이상반응 보고
| VAERS ID | 1133447 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | |
| 접종일 | 2021-02-26 |
| 발병일 | 2021-03-04 |
| 상태 | 입원 사망 |
증상
- 혈액 검사(Blood test)
- 흉부 엑스레이(Chest X-ray)
- 심방 세동(Atrial fibrillation)
- 요로증(Urosepsis)
이환 중 질병
지병
Medical History/Concurrent Conditions: Parkinson's disease
기타 의료
BUTRANS; LEPONEX
이전 예방접종
알레르기
임상 검사
Test Name: blood test; Result Unstructured Data: Test Result:unknown; Test Name: X thorax; Result Unstructured Data: Test Result:unknown
증상 상세
Atrial fibrillation; Urosepsis; This is a spontaneous report from a contactable consumer.
This is a report received from the regulatory authority.
Regulatory authority or other manufacturer number NL-LRB-00473895.
An 84-years-old female patient received BNT162B2 (COMIRNATY) via an unspecified route of administration on 26Feb2021 at single dose for COVID-19 immunisation.
Medical history included parkinson's disease.
Concomitant medication(s) included buprenorphine (BUTRANS), clozapine (LEPONEX).
The patient received the vaccine, 6 days later (on 04Mar2021) she was admitted with urosepsis and atrial fibrillation, 5 days later (09Mar2021) she died.
Atrial fibrillation is treated with Ceftriaxon and urosepsis is treated with Ceftriaxon.
Parkinson was reported as confounding factors.
Lab data and diagnostic procedures included blood test and X thorax.
The patient died on 09Mar2021.
It was not reported if an autopsy was performed.
No follow-up attempts possible.
No further information expected.
Lot/batch number cannot be obtained.
; Reported Cause(s) of Death: Atrial fibrillation; urosepsis